Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cronos Group Inc

Healthcare CA CRON

3.76CAD
-0.1(2.59%)

Last update at 2026-06-12T20:00:00Z

Day Range

3.753.86
LowHigh

52 Week Range

2.474.66
LowHigh

Fundamentals

  • Previous Close 3.86
  • Market Cap1435.85M
  • Volume142195
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.35300M
  • Revenue TTM146.59M
  • Revenue Per Share TTM0.38
  • Gross Profit TTM 58.40M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.41969M 36.55M -73.49249M -134.55900M -397.13500M
Minority interest -6.51800M 1.06M 0.59M 0.00000M 1.10M
Net income -9.61237M 41.04M -73.78578M -168.73400M -396.70400M
Selling general administrative 70.81M 76.82M 58.23M 86.29M 106.63M
Selling and marketing expenses - - 22.70M 22.28M 44.94M
Gross profit 61.70M 30.45M 11.88M 11.97M -17.53400M
Reconciled depreciation 14.23M 9.34M 8.11M 13.12M 15.40M
Ebit -17.83891M -54.21349M -79.71853M -116.01200M 6.79M
Ebitda -3.35879M -45.37189M -72.27940M -59.18500M 22.19M
Depreciation and amortization 14.48M 8.84M 7.44M 56.83M 15.40M
Non operating income net other - - - - -
Operating income -17.83891M -76.45636M -84.59682M -116.01200M 6.79M
Other operating expenses 166.99M 193.96M 171.63M 207.92M 271.35M
Interest expense - - - 22.54M 0.03M
Tax provision -14.19100M -3.43600M -3.23000M 34.17M -0.43100M
Interest income 39.96M 138.51M 51.23M 52.16M 162.73M
Net interest income 39.96M 52.02M 51.23M 22.54M 9.07M
Extraordinary items - 0.00000M -4.11400M 0.00000M -0.50000M
Non recurring - - - - -
Other items - - - - -
Income tax expense -14.43942M -3.43600M -3.23000M 34.17M -0.43100M
Total revenue 149.15M 117.50M 87.03M 91.90M 74.44M
Total operating expenses 79.54M 106.91M 96.48M 127.98M 179.38M
Cost of revenue 87.45M 87.05M 75.15M 79.94M 91.97M
Total other income expense net 0.42M 113.01M 11.10M -18.54700M -403.92000M
Discontinued operations - - - - -0.50000M
Net income from continuing ops -2.92900M 40.02M -70.43900M -168.73400M -396.70400M
Net income applicable to common shares - 41.08M -73.96300M -168.73400M -396.10700M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1194.96M 1166.31M 1140.09M 1213.01M 1397.74M
Intangible assets 8.87M 11.13M 21.08M 26.70M 18.08M
Earning assets - - - - -
Other current assets 8.33M 6.28M 5.41M 7.11M 8.97M
Total liab 54.08M 55.33M 43.96M 72.05M 63.46M
Total stockholder equity 1091.91M 1064.06M 1099.57M 1143.88M 1337.24M
Deferred long term liab - - - - -
Other current liab 36.14M 0.04M 0.10M 55.62M 40.44M
Common stock 661.78M - 613.73M 611.32M 595.50M
Capital stock 662.98M 669.88M 613.73M 611.32M 595.50M
Retained earnings 446.94M 457.71M 416.72M 490.68M 659.42M
Other liab - - - 1.38M 1.99M
Good will 66.36M 63.45M 1.06M 1.03M 1.10M
Other assets - - - 0.19M 80.73M
Cash 790.35M 858.80M 669.29M 764.64M 886.97M
Cash and equivalents - - - 764.64M 886.97M
Total current liabilities 48.10M 49.70M 41.40M 68.12M 54.37M
Current deferred revenue - - 28.17M - -
Net debt -787.67693M - -666.73800M -760.76800M -877.16700M
Short term debt 0.34M - 0.99M 1.33M 2.71M
Short long term debt - - - - -
Short long term debt total 2.68M - 2.55M 3.88M 9.81M
Other stockholder equity - - 48.45M 42.68M 32.47M
Property plant equipment - - - 62.83M 82.95M
Total current assets 942.37M 936.11M 933.31M 960.16M 1079.72M
Long term investments 7.66M 2.81M 54.74M 89.75M 135.16M
Net tangible assets - - - 1116.15M 1318.07M
Short term investments 39.93M 0.00000M 192.24M 113.08M 117.68M
Net receivables 57.09M 15.46M 35.88M 37.77M 33.29M
Long term debt - - - - -
Inventory 46.66M 33.15M 30.50M 37.56M 32.80M
Accounts payable 11.62M 16.97M 12.13M 11.16M 11.22M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -16.81135M - 20.68M -0.79700M 49.87M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 0.04M 72.54M 80.73M
Deferred long term asset charges - - - - -
Non current assets total 252.59M 230.07M 206.78M 252.85M 318.02M
Capital lease obligations 1.51M 2.02M 2.55M 3.88M 9.81M
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -45.10700M 175.15M -59.49900M -1.84200M -19.40600M
Change to liabilities - - - -0.86300M -2.37300M
Total cashflows from investing activities -77.89920M 175.15M -59.49900M -1.84200M -28.89800M
Net borrowings - - - - -
Total cash from financing activities -20.25345M -1.23100M -1.03000M -2.89700M -13.44200M
Change to operating activities - - - -2.75800M 1.97M
Net income -9.61237M 40.02M -74.55300M -168.73400M -397.20400M
Change in cash -109.07105M 189.51M -95.35300M -122.32900M -191.05000M
Begin period cash flow 899.42M 669.29M 764.64M 886.97M 1078.02M
End period cash flow 790.35M 858.80M 669.29M 764.64M 886.97M
Total cash from operating activities 26.32M 18.84M -42.83500M -88.94800M -153.61600M
Issuance of capital stock - - - - -
Depreciation 14.48M 9.34M 8.11M 13.12M 15.40M
Other cashflows from investing activities - -4.25000M 18.61M 3.19M -16.63600M
Dividends paid - - - - -
Change to inventory -10.57697M 7.42M 7.40M -7.21700M 11.56M
Change to account receivables -26.20382M -2.51400M 9.21M -2.71100M -13.16300M
Sale purchase of stock -9.91152M - -1.36472M - 0.02M
Other cashflows from financing activities -10.34193M -1.23100M -1.03000M -2.89700M -13.44200M
Change to netincome - - - 46.00M 229.09M
Capital expenditures 26.17M 13.15M 3.42M 5.03M 12.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -35.01643M -0.31100M -26.46800M 20.66M -2.00500M
Stock based compensation 7.05M 8.70M 8.77M 15.12M 10.15M
Other non cash items 56.47M -38.90400M -2.00800M 30.89M 220.04M
Free cash flow 0.15M 5.69M -46.25800M -93.98000M -165.87800M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRON
Cronos Group Inc		 -0.1 2.59% 3.76 - 32.15 9.80 0.95 1.47 1.90
CURA
Curaleaf Holdings Inc.		 -0.72 4.95% 13.84 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc		 -0.11 1.53% 7.09 13.98 1.35 0.28 18.74 2.12 6.84
TLRY
Tilray Inc		 -0.17 2.38% 6.96 - 1000.00 1.28 0.53 1.08 -2.299
GUD
Knight Therapeutics Inc.		 0.10 1.07% 9.48 - 48.54 1.64 0.96 1.60 11.97

Reports Covered

Stock Research & News

View All

Profile

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Cronos Group Inc

4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0

Key Executives

Name Title Year Born
Mr. Michael Ryan Gorenstein J.D. Pres, CEO & Chairman 1987
Ms. Shannon Buggy Sr. VP & Global Head of People 1970
Ms. Anna Shlimak Sr. VP of Corp. Affairs & Strategy 1986
Mr. James Holm Chief Financial Officer NA
Mr. Carlos Cortez VP, Controller & Principal Accounting Officer 1973
Mr. Shayne J. Laidlaw Director of Investor Relations & Strategy NA
Mr. Terry Gregory-Joseph Doucet Sr. VP of Legal & Regulatory Affairs and Corp. Sec. 1990
Mr. Jeffrey David Jacobson Chief Growth Officer 1986
Mr. Arye Weigensberg Head of R&D NA
Mr. Kevin B Gifford VP of Fin. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.